Human Genome Epidemiology Literature Finder
|
Records 1 - 5 (of 5 Records) |
| Query Trace: Adenoma and UGT1A6[original query] |
|---|
| CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk. Cancer research 2001 May 61 (9): 3566-9. Bigler J, Whitton J, Lampe J W, Fosdick L, Bostick R M, Potter J |
| Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma. Journal of the National Cancer Institute 2005 Mar 97 (6): 457-60. Chan Andrew T, Tranah Gregory J, Giovannucci Edward L, Hunter David J, Fuchs Charles |
| Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrence. Clinical cancer research : an official journal of the American Association for Cancer Research 2006 Nov 12 (21): 6585-9. Hubner Richard A, Muir Kenneth R, Liu Jo-Fen, Logan Richard F A, Grainge Matthew, Armitage Nicholas, Shepherd Vic, Popat Sanjay, Houlston Richard S, |
| The influence of UGT1A6 variants and aspirin use in a randomized trial of celecoxib for prevention of colorectal adenoma. Cancer prevention research (Philadelphia, Pa.) 2012 Jan 5 (1): 61-72. Chan Andrew T, Hsu Meier, Zauber Ann G, Hawk Ernest T, Bertagnolli Monica |
| Novel Methods of Risk Stratifying Patients for Metachronous, Pre-Malignant Colorectal Polyps: A Systematic Review. Critical reviews in oncology/hematology 2021 7 164 103421. Johnstone Mark S, Lynch Gerard, Park James, McSorley Stephen, Edwards Joan |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: